KHK4083: Clinical Trials

2 trials of KHK4083, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow KHK4083: new trials by email Literature Review of KHK4083 trials Research Report on KHK4083

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis
KHK4083, Placebo - Atopic Dermatitis
Phase 2CompletedKyowa Kirin, Inc.2742018-10-222024-04-26
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis
KHK4083, Placebo - Ulcerative Colitis, Digestive System Diseases
Phase 2CompletedKyowa Kirin, Inc.662016-06-012024-04-26

Conditions studied

Abdominal Pain (1)  ·  Autoimmune Diseases (1)  ·  Colitis (1)  ·  Colitis, Ulcerative (1)  ·  Colonic Diseases (1)  ·  Dermatitis, Atopic (1)  ·  Digestive System Diseases (1)  ·  Eczema (1)  ·  Gastrointestinal Diseases (1)  ·  Inflammatory Bowel Diseases (1)  ·  Intestinal Diseases (1)  ·  Skin Diseases (1)

Sponsors

Kyowa Kirin, Inc. (2)

Countries

United States (2)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Japan (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  Serbia (1)

Top investigators

Ehsanollah Esfandiari, MD, PhD (1)  ·  Vincent Strout, MBA (1)

Results publications

PMID 36509097, PMID 39532780